OEM News

Advita Ortho Unveils Axis Clinical Research Initiative for Shoulder Surgeons

Axis draws on more than 20 years of shoulder data from 25,000+ patients across 45 global clinical sites.

Photo: Advita Ortho

Advita Ortho has launched Axis, a clinical research initiative that aims to link shoulder surgeons with the growing body of evidence for shoulder arthroplasty.

According to the Gainesville, Florida-based company, Axis draws on more than 20 years of shoulder data from 25,000+ patients across 45 global clinical sites, supporting 250+ peer-reviewed publications and dozens of first-to-market product innovations.

The new Axis website summarizes findings from the Equinoxe multicenter international research team, including study summaries, clinical questions, author interviews, and information on the Axis Research Council, clinical sites, and data collection.

The launch follows Advita’s expansion of clinical research using more than two decades of shoulder data. At the International Congress of Shoulder and Elbow Surgery (ICSES) in Vancouver, Canada, the company will present research on computer-assisted navigation, CT-based radiomics, predictive analytics, infection risk, and other factors affecting shoulder arthroplasty outcomes.

Advita researchers also presented shoulder and knee studies at the International Society for Technology in Arthroplasty (ISTA) in Munich, Germany, covering computer-assisted navigation, implant design, dynamic alignment, machine learning, and clinical outcomes.

In August, the company launched “Guided by What Matters”, a campaign for its Advita GPS surgeon-controlled real-time guidance platform for shoulder, knee and ankle replacement.

Comments from Advita Ortho and clinicians

Chris Roche, Advita’s senior VP of Extremities: “Clinical research is the foundation of Advita’s technologies and innovations. With Axis, we are sharing the results of more than 20 years of collaboration between surgeon researchers, clinical coordinators and Advita’s development team, distilling the findings of our most high-impact studies in a new, more approachable format. Our goal is to amplify the most generalizable conclusions from our published studies and provide a forum for the researchers to explain why they performed a given study and discuss how they’ve integrated these findings in their clinical practice—ultimately allowing surgeons to help improve clinical outcomes and better serve patients.”

Joseph Zuckerman, MD, research team member: “The strength of your conclusions in research is based on the number of patients in your study, because then it’s much more robust, generalizable and reliable. And we have that now. When we report the results of a specific outcome, we’re not reporting 30, 40, 50 patients, we’re reporting 300, 400, 1500, 2000 cases. No other orthopedic company has a database this massive with as long a history.”

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters